Bioreducible liposomes for gene delivery: From the formulation to the mechanism of action

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Candiani, Gabriele ^a   Pezzoli, Daniele ^a   Ciani, Laura ^b   Chiesa, Roberto ^a   Ristori, Sandra ^b  

^a POLITECNICO DI MILANO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMYRISTOYL GLYCERO 3 PHOSPHATIDYLCHOLINE; 1,2 DIMYRISTOYL GLYCERO 3 PHOSPHATIDYLETHANOLAMINE; 1,2 DIOLEOYL GLYCERO 3 PHOSPHATIDYLCHOLINE; 1,2 DIOLEOYL GLYCERO 3 PHOSPHATIDYLETHANOLAMINE; GLUTATHIONE; LIPID; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; PLASMID DNA; SS14; UNCLASSIFIED DRUG; SURFACTANT;

ANIMAL CELL; ARTICLE; CELL TYPE; CELL VIABILITY; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID COMPOSITION; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PROTEIN CONTENT; ZETA POTENTIAL; GENE TRANSFER; PARTICLE SIZE; SYNTHESIS;

GENE TRANSFER TECHNIQUES; LIPOSOMES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 78149426793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013430     Document Type: Article

References (67)

1. Gao X, Kim KS, Liu D (2007) Nonviral gene delivery: what we know and what is next. AAPS J 9: E92-104.
2. Mintzer MA, Simanek EE (2009) Nonviral vectors for gene delivery. Chem Rev 109: 259-302.
3. Eliyahu H, Barenholz Y, Domb AJ (2005) Polymers for DNA delivery. Molecules 10: 34-64.
4. Giordano C, Causa F, Candiani G (2006) Gene therapy: The state of the art and future directions. Journal of Applied Biomaterials & Biomechanics 4: 73-79.
5. Ganta S, Devalapally H, Shahiwala A, Amiji M (2008) A review of stimuliresponsive nanocarriers for drug and gene delivery. J Control Release 126: 187-204.
6. Guo X, Szoka FC, Jr. (2003) Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc Chem Res 36: 335-341.
7. Saito G, Swanson JA, Lee KD (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 55: 199-215.
8. Blessing T, Remy JS, Behr JP (1998) Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A 95: 1427-1431.
9. Tang F, Hughes JA (1999) Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro. Bioconjugate chemistry 10: 791-796.
10. Wetzer B, Byk G, Frederic M, Airiau M, Blanche F, et al. (2001) Reducible cationic lipids for gene transfer. Biochem J 356: 747-756.
11. Read ML, Bremner KH, Oupicky D, Green NK, Searle PF, et al. (2003) Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J Gene Med 5: 232-245.
12. Ciani L, Candiani G, Frati A, Ristori S (2010) DNA induced dimerization of a sulfhydryl surfactant in transfection agents studied by ESR spectroscopy. Biophysical Chemistry 151: 81-85.
13. Bauhuber S, Hozsa C, Breunig M, Gopferich A (2009) Delivery of Nucleic Acids via Disulfide-Based Carrier Systems. Advanced Materials 21: 3286-3306.
14. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, et al. (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84: 7413-7417.
15. Hui SW, Langner M, Zhao YL, Ross P, Hurley E, et al. (1996) The role of helper lipids in cationic liposome-mediated gene transfer. Biophys J 71: 590-599.
16. Thierry AR, Rabinovich P, Peng B, Mahan LC, Bryant JL, et al. (1997) Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Ther 4: 226-237.
17. Simberg D, Danino D, Talmon Y, Minsky A, Ferrari ME, et al. (2001) Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J Biol Chem 276: 47453-47459.
18. Ewert K, Ahmad A, Evans HM, Schmidt HW, Safinya CR (2002) Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. J Med Chem 45: 5023-5029.
19. Koynova R, MacDonald RC (2005) Lipid transfer between cationic vesicles and lipid-DNA lipoplexes: effect of serum. Biochim Biophys Acta 1714: 63-70.
20. Zelphati O, Szoka FC, Jr. (1996) Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci U S A 93: 11493-11498.
21. Ciani L, Ristori S, Salvati A, Calamai L, Martini G (2004) DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra. Biochim Biophys Acta 1664: 70-79.
22. Bajaj A, Kondiah P, Bhattacharya S (2007) Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: a structure-activity investigation. J Med Chem 50: 2432-2442.
23. Kirby AJ, Camilleri P, Engberts JB, Feiters MC, Nolte RJ, et al. (2003) Gemini surfactants: new synthetic vectors for gene transfection. Angew Chem Int Ed Engl 42: 1448-1457.
24. Bhattacharya S, De S, George SK (1997) Synthesis and vesicle formation from novel pseudoglyceryl dimeric lipids. Evidence of formation of widely different membrane organizations with exceptional thermotropic properties. Chemical Communications. pp 2287-2288.
25. Bhattacharya S, De S (1999) Synthesis and vesicle formation from dimeric pseudoglyceryl lipids with (CH2)(m) spacers: pronounced m-value dependence of thermal properties, vesicle fusion, and cholesterol complexation. Chemistry-a European Journal 5: 2335-2347.
26. McGregor C, Perrin C, Monck M, Camilleri P, Kirby AJ (2001) Rational approaches to the design of cationic gemini surfactants for gene delivery. J Am Chem Soc 123: 6215-6220.
27. Candiani G, Frigerio M, Viani F, Verpelli C, Sala C, et al. (2007) Dimerizable redox-sensitive triazine-based cationic lipids for in vitro gene delivery. ChemMedChem 2: 292-296.
28. Bombelli C, Faggioli F, Luciani P, Mancini G, Sacco MG (2005) Efficient transfection of DNA by liposomes formulated with cationic gemini amphiphiles. J Med Chem 48: 5378-5382.
29. Candiani G, Pezzoli D, Cabras M, Ristori S, Pellegrini C, et al. (2008) A dimerizable cationic lipid with potential for gene delivery. J Gene Med 10: 637-645.
30. Huynh GH, Deen DF, Szoka FC (2006) Barriers to carrier mediated drug and gene delivery to brain tumors. Journal of Controlled Release 110: 236-259.
31. MacKay JA, Li W, Huang Z, Dy EE, Huynh G, et al. (2008) HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convectionenhanced delivery. Molecular Therapy 16: 893-900.
32. Congiu A, Pozzi D, Esposito C, Castellano C, Mossa G (2004) Correlation between structure and transfection efficiency: a study of DC-Chol--DOPE/DNA complexes. Colloids Surf B Biointerfaces 36: 43-48.
33. Yang JP, Huang L (1997) Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther 4: 950-960.
34. Boomer JA, Thompson DH, Sullivan SM (2002) Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer. Pharm Res 19: 1292-1301.
35. Audouy S, Molema G, de Leij L, Hoekstra D (2000) Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. J Gene Med 2: 465-476.
36. Bagnacani V, Sansone F, Donofrio G, Baldini L, Casnati A, et al. (2008) Macrocyclic nonviral vectors: high cell transfection efficiency and low toxicity in a lower rim guanidinium calix[4]arene. Org Lett 10: 3953-3956.
37. Kim A, Lee EH, Choi SH, Kim CK (2004) In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 25: 305-313.
38. Walker WE, Porteous DJ, Boyd AC (2004) The effects of plasmid copy number and sequence context upon transfection efficiency. J Control Release 94: 245-252.
39. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, et al. (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269: 2550-2561.
40. Caracciolo G, Pozzi D, Caminiti R, Marchini C, Montani M, et al. (2007) Transfection efficiency boost by designer multicomponent lipoplexes. Biochim Biophys Acta 1768: 2280-2292.
41. Caracciolo G, Pozzi D, Caminiti R, Marchini C, Montani M, et al. (2008) Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density. J Phys Chem B 112: 11298-11304.
42. Litzinger DC, Huang L (1992) Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochim Biophys Acta 1113: 201-227.
43. Shangguan T, Cabral-Lilly D, Purandare U, Godin N, Ahl P, et al. (2000) A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine- condensed plasmid DNA. Gene Ther 7: 769-783.
44. Farhood H, Serbina N, Huang L (1995) The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1235: 289-295.
45. Pinnaduwage P, Schmitt L, Huang L (1989) Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells. Biochim Biophys Acta 985: 33-37.
46. Manickam DS, Hirata A, Putt DA, Lash LH, Hirata F, et al. (2008) Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of nonviral redox-responsive delivery vectors. Biomaterials 29: 2680-2688.
47. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711-760.
48. Hwang C, Sinskey AJ, Lodish HF (1992) Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257: 1496-1502.
49. Manickam DS, Li J, Putt DA, Zhou QH, Wu C, et al. (2010) Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors. J Control Release 141: 77-84.
50. Jeong JH, Kim SH, Christensen LV, Feijen J, Kim SW (2010) Reducible poly(amido ethylenimine)-based gene delivery system for improved nucleus trafficking of plasmid DNA. Bioconjug Chem 21: 296-301.
51. Turanov AA, Kehr S, Marino SM, Yoo MH, Carlson BA, et al. (2010) Mammalian thioredoxin reductase 1: roles in redox homeostasis and charcterization of cellular targets. Biochem J.
52. Limon-Pacheco JH, Hernandez NA, Fanjul-Moles ML, Gonsebatt ME (2007) Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic Biol Med 43: 1335-1347.
53. Gilge JL, Fisher M, Chai YC (2008) The effect of oxidant and the non-oxidant alteration of cellular thiol concentration on the formation of protein mixeddisulfides in HEK 293 cells. PLoS One 3: e4015.
54. Allen RG, Tresini M (2000) Oxidative stress and gene regulation. Free Radic Biol Med 28: 463-499.
55. Chen J, Small-Howard A, Yin A, Berry MJ (2005) The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO). BMC Neurosci 6: 10.
56. Adamy C, Mulder P, Khouzami L, Andrieu-abadie N, Defer N, et al. (2007) Neutral sphingomyelinase inhibition participates to the benefits of Nacetylcysteine treatment in post-myocardial infarction failing heart rats. J Mol Cell Cardiol 43: 344-353.
57. Adamy C, Le Corvoisier P, Candiani G, Kirsch M, Pavoine C, et al. (2005) Tumor necrosis factor alpha and glutathione interplay in chronic heart failure. Arch Mal Coeur Vaiss 98: 906-912.
58. Shang F, Lu M, Dudek E, Reddan J, Taylor A (2003) Vitamin C and vitamin E restore the resistance of GSH-depleted lens cells to H2O2. Free Radic Biol Med 34: 521-530.
59. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P, Jr., et al. (1998) Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 24: 699-704.
60. Damy T, Kirsch M, Khouzami L, Caramelle P, Le Corvoisier P, et al. (2009) Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities. PLoS One 4: e4871.
61. Yao JK, Dougherty GG, Jr., Reddy RD, Keshavan MS, Montrose DM, et al. (2010) Homeostatic imbalance of purine catabolism in first-episode neurolepticnaive patients with schizophrenia. PLoS One 5: e9508.
62. Bahlis NJ, McCafferty-Grad J, Jordan-McMurry I, Neil J, Reis I, et al. (2002) Feasibility and correlates of arsenic trioxide combined with ascorbic acidmediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin Cancer Res 8: 3658-3668.
63. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54: 4313-4320.
64. Ray G, Batra S, Shukla NK, Deo S, Raina V, et al. (2000) Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59: 163-170.
65. Skrzydlewska E, Kozuszko B, Sulkowska M, Bogdan Z, Kozlowski M, et al. (2003) Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology 50: 126-131.
66. Kretzschmar M (1996) Regulation of hepatic glutathione metabolism and its role in hepatotoxicity. Exp Toxicol Pathol 48: 439-446.
67. Ohashi T, Mizutani A, Murakami A, Kojo S, Ishii T, et al. (2002) Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett 511: 21-27.